Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12268737
Stabilized influenza hemagglutinin stem region trimers and uses thereof
granted -
US 12268673
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 12268678
Formulations of hydroxypyridonate actinide/lanthanide decorporation agents
granted -
US 12268688
Compositions and methods of use for modified release minoxidil
granted -
US 12269887
Anti-canine CD16 polypeptides, anti-canine CD64 polypeptides, compositions including same, and methods of using
granted -
US 12269856
Hepcidin analogues and uses thereof
granted -
US 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted -
US 12269858
Activin receptor type IIB variants and methods of use thereof
granted -
US 12269155
Multivalent vaccines for rabies virus and coronaviruses
granted -
US 12269801
Modified amino acids
granted -
US 12269872
Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use
granted -
US 12270050
Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using
granted -
US 12269808
Amino dithioperacid thioester compound, preparation method therefor, and use thereof
granted -
US 12270814
Kits and methods for prediction and treatment of preeclampsia
granted -
US 12269803
Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease
granted -
US 12268753
Nanomaterials comprising a biodegradable feature
granted -
US 12268777
Compositions and methods for treating eosinophilic disorders
granted -
US 12269831
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 12268730
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 12269820
Piperazine substituted indazole compounds as inhibitors of PARG
granted -
US 12270080
NcRNA and uses thereof
granted -
US 12269805
Inhibitors of platelet function and methods for use of the same
granted -
US 12269889
Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels
granted -
US 12268831
Swallowable drug delivery device and methods of drug delivery
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.